Posted in | News | Gold | Mining Business

Globex Mining Provides Update on Current Developments at Montalembert Property

GLOBEX MINING ENTERPRISES INC. is pleased to inform shareholders that Enforcer Gold Corp. has reported visible gold in core (DDH MDD 17006) and outcrop (see Enforcer press release dated July 26) in current work undertaken on the Montalembert property, under option from Globex.

Some 260 rock samples collected from mapping in an area 1.5 km x 1.5 km have been sent for assay along with 490 m of channel samples from trench exposures including the No. 3 Vein located approximately 175 m south and along strike of the No. 2 Vein.

Twenty large diameter HQ drill holes totaling some 2,227 m have been completed as well as 45 km of an induced polarization survey. Eighteen of the drill holes are in for assay. Geological team are currently focusing upon following up on ground truthing anomalies indicated by the IP survey and a previous VLF-EM airborne survey.

Globex is pleased by the scope of the work and the dedication to the development of the project demonstrated by Enforcer who has earmarked $2.2 million to exploration on the claims at Montalembert for this year.

For additional details, please see the Enforcer press release of August 15, 2017 and visit their website www.enforcergold.com to see photographs of visible gold in channel samples and drill core. For terms of the option agreement between Globex and Enforcer (formerly Natan Resources) please see Globex's press release dated November 17, 2016.

This press release was written by Jack Stoch, P. Geo., President and CEO of Globex in his capacity as a Qualified Person (Q.P.) under NI 43-101.

Source: http://www.globexmining.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.